Top Story

AMA urges Senate to reject Graham-Cassidy proposal

September 20, 2017

The AMA recently sent a letter to Senate Majority Leader Mitch McConnell and Minority Leader Charles Schumer strongly opposing the Graham-Cassidy legislation, emphasizing that the bill would result in the loss of health insurance coverage for millions of Americans while destabilizing health insurance markets.

“Similar to proposals that were considered in the Senate in July, we believe the Graham-Cassidy Amendment would result in millions of Americans losing their health insurance coverage, destabilize health insurance markets, and decrease access to affordable coverage and care,” James L. Madara, MD, CEO and executive vice president of AMA, wrote in the letter.

Meeting NewsVideo

VIDEO: Additional treatment with ALK inhibitor after progression shows promise in non-small cell lung cancer

September 18, 2017
CHICAGO — Ensartinib shows promise for the treatment of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer, Makenzi Evangelist
In the Journals

Patients with HIV who smoke at greater risk for lung cancer mortality

September 18, 2017
Patients with HIV who adhere to antiretroviral therapy but smoke are significantly more likely to die from lung cancer than from AIDS-related causes; therefore, smoking…
Meeting News

Smoking status does not impact outcomes with anti-PD-1 therapy

September 18, 2017
CHICAGO — Smoking status did not affect biomarkers, immune-related adverse events or survival among patients treated with anti-PD-1 therapy for non-small cell lung…
More Headlines »
Feature Article

Use of Electronic Nicotine Delivery Systems Among Adolescents: Status of the Evidence and Public Health Recommendations

Pediatric Annals, February 2017, Volume 46 Issue 2
Although the prevalence of tobacco smoking has been declining in recent years, the use of electronic nicotine delivery…
More »
Meeting News

VIDEO: Gefitinib may ‘change the paradigm’ to treat lung cancer

August 10, 2017
More »